Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Regulatory and Economic Aspects in Oncology

BuchGebunden
205 Seiten
Englisch
Springererschienen am23.01.20191st ed. 2019
This book explores topics of importance to all who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to their marketing authorization and pricing.mehr
Verfügbare Formate
BuchGebunden
EUR128,39
E-BookPDF1 - PDF WatermarkE-Book
EUR117,69

Produkt

KlappentextThis book explores topics of importance to all who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to their marketing authorization and pricing.
Details
ISBN/GTIN978-3-030-01206-9
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2019
Erscheinungsdatum23.01.2019
Auflage1st ed. 2019
Seiten205 Seiten
SpracheEnglisch
Gewicht542 g
IllustrationenVII, 205 p. 14 illus., 12 illus. in color.
Artikel-Nr.15930130
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
The growing health burden of cancer: a global epidemiological overview.-Cost of Cancer Care: Health expenditures and economic impact.- Innovation in R&D: An answer to cancer.- The Evaluation of Benefits, Harms and Costs of Cancer Screening.- Oncology from a HTA and health economic perspective.- Heterogeneous recommendations for oncology products among different HTA systems: a comparative assessment.- Outcomes in oncology: clinical vs. patient-reported outcome performance measures.- The value of patient-reported outcome in health economic decision making: a changing landscape in oncology.- Approaches to capture value in oncology.- Orphan durgs in oncology.- Recent developments in health economic modeling of cancer therapies.- Drug pricing and value in oncology.- Pharmaceutical price regulation of cancer treatments.- Regulatory and evidence requirements and the changing landscape in regulation for marketing authorization.- Looking for Willingness to Pay (WTP) Threshold for a QALY in oncology.- Equity and patient access to innovative cancer treatments.mehr
Kritik
"The book is written at multiple levels, so that it provides very useful information about health economics for oncology and the factors that drive policy in a fashion that would be useful for training oncologists, senior nurses, physicians, administrators, and, importantly, policymakers and the medical advisors of politicians. ... I recommend this book highly to medical librarians." (Derek Raghavan, Doody's Book Reviews, August 30, 2019)mehr

Schlagworte

Autor


Dr. Evelyn Walter has been head (and co-founder) of the Institute of Pharmaeconomic Research (IPF) in Vienna since 2003. The IPF´s main areas include health economic evaluation, modeling, and expert advice on reimbursement decisions, pharmaceutical pricing and distribution. She first studied Mathematics at Vienna University of Technology, before switching to the Vienna University of Economic Sciences, where she completed a Master´s and a doctorate in Economics. She has authored or co-authored some 60 publications, chiefly in refereed journals, and serves as a reviewer for several health economics journals. In Austria, she initiated the Guidelines for Health Evaluation. She is a Member of the Scientific Advisory Board for the System of Health Accounts at Statistic Austria. As a member of ISPOR (the International Society of Pharmacoeconomics and outcome Research) she co-chaired the 17th and 18th Annual European Congresses. Dr. Walter is a Lecturer at the University of Applied Sciences in Burgenland, where she teaches courses on Health Economics, Health Technology Assessment and Pharma Management. 


Weitere Artikel von
Herausgegeben von Walter, Evelyn